02689nam 2200517 a 450 991078315960332120230422043240.00-8330-4361-7(CKB)1000000000007710(EBL)3031483(SSID)ssj0000284599(PQKBManifestationID)11227418(PQKBTitleCode)TC0000284599(PQKBWorkID)10261469(PQKB)11570556(Au-PeEL)EBL3031483(CaPaEBR)ebr2004585(OCoLC)70763898(MiAaPQ)EBC3031483(EXLCZ)99100000000000771019991210d2000 uh 0engur|n|---|||||txtccrSupporting expeditionary aerospace forces new agile combat support postures /Lionel Galway [et al.]Santa Monica, Ca Rand20001 online resource (xx, 46 pages) illustrations"MR-1075-AF."0-8330-2801-4 Includes bibliographical references (p. 45-46).""PREFACE""; ""PROJECT AIR FORCE""; ""FIGURES""; ""TABLES""; ""SUMMARY""; ""INTRODUCTION AND MOTIVATION""; ""GENERAL ANALYTIC FRAMEWORK""; ""SUPPORT INFRASTRUCTURE COMPONENTS: FOLs AND FSLs""; ""EXPEDITIONARY DEPLOYMENT PERFORMANCE: PROTOTYPE ANALYSIS""; ""ANALYZING OPTIONS FOR EXPEDITIONARY ACS""; ""ACKNOWLEDGMENTS""; ""ACRONYMS""; ""THE NEW SECURITY ENVIRONMENT AND THE USAF""; ""THE EXPEDITIONARY AEROSPACE FORCE""; ""EXPEDITIONARY COMBAT SUPPORT""; ""THEATER INFRASTRUCTURE PREPARATION""; ""GENERAL ANALYTIC FRAMEWORK""; ""DETAILED DESCRIPTION""; ""MODELS AND CURRENT STATUS""""DATA SOURCES""""INTEGRATING MODELS""; ""SUPPORT INFRASTRUCTURE COMPONENTS: FOLs AND FSLs""; ""CATEGORIES OF FOL""; ""Category 3""; ""Category 2""; ""Category 1""; ""SUPPLYING THE DIFFERENCE: FSLs AND CONUS""; ""EXPEDITIONARY DEPLOYMENT PERFORMANCE: PROTOTYPE ANALYSIS""; ""EAF SCENARIOS""; ""PERFORMANCE METRICS""; ""SCENARIO DEPLOYMENT PERFORMANCE""; ""Timelines to Deploy to Categories of FOL""; ""Deployment Footprint""; ""Peacetime Cost Estimates""; ""EFFECTS OF DIFFERENT TECHNOLOGIES ON DEPLOYMENT PERFORMANCE""; ""CONCLUSIONS""; ""ANALYZING OPTIONS FOR EXPEDITIONARY ACS""""MODEL OUTPUT FOR PROTOTYPE CASES""""BIBLIOGRAPHY""Space warfareSpace warfare.358/.8/0973Galway Lionel A.1950-1138240MiAaPQMiAaPQMiAaPQBOOK9910783159603321Supporting expeditionary aerospace forces3720710UNINA03540nam 22005895 450 991030021210332120200630072524.03-319-16949-110.1007/978-3-319-16949-1(CKB)3710000000412173(EBL)2094671(SSID)ssj0001501580(PQKBManifestationID)11901922(PQKBTitleCode)TC0001501580(PQKBWorkID)11446981(PQKB)11047396(DE-He213)978-3-319-16949-1(MiAaPQ)EBC2094671(PPN)186026358(EXLCZ)99371000000041217320150506d2015 u| 0engur|n|---|||||txtccrLocal Treatment of Inflammatory Joint Diseases Benefits and Risks /edited by Willm Uwe Kampen, Manfred Fischer1st ed. 2015.Cham :Springer International Publishing :Imprint: Springer,2015.1 online resource (147 p.)Description based upon print version of record.3-319-16948-3 Includes bibliographical references.Preface -- Histopathology of synovitis -- Non-radioactive treatment of synovitis (risk-benefit) -- Introduction to radiosynoviorthesis (RSO) -- Dosimetry and radiation burden -- Local complications and possible treatment strategies -- Risk of malignoma induction -- Baker´s cysts – a relevant contraindication?.- Analysis of periodic update reports -- Summary.This book presents a systematic survey of different local treatments in inflammatory joint diseases and their potential side effects and complications. Both surgical therapies and pharmaceutical strategies involving local or systemic application of anti-inflammatory and immunomodulating drugs are addressed. Special emphasis is placed on nuclear medicine therapy by intra-articular instillation of beta radiation emitters, known as radiosynoviorthesis or radiation synovectomy. Possible complications, in particular radionecrosis, infection, and thromboembolism, are described and available treatment strategies are examined in detail. In addition, radiation safety considerations are critically reviewed and relevant clinical questions are discussed.  While radiosynoviorthesis is an effective and safe treatment if a proper indication is secured and if the application is performed by an experienced nuclear medicine physician, local complications can never be excluded with certainty. This book will support physicians who are engaged in the care and treatment of patients with inflammatory joint disease, approximately 30,000 of whom undergo radiosynoviorthesis in Europe each year.  .Nuclear medicineRadiotherapyNuclear Medicinehttps://scigraph.springernature.com/ontologies/product-market-codes/H29048Radiotherapyhttps://scigraph.springernature.com/ontologies/product-market-codes/H29056Nuclear medicine.Radiotherapy.Nuclear Medicine.Radiotherapy.610615842616.07548Kampen Willm Uweedthttp://id.loc.gov/vocabulary/relators/edtFischer Manfrededthttp://id.loc.gov/vocabulary/relators/edtBOOK9910300212103321Local Treatment of Inflammatory Joint Diseases2533814UNINA